First recombinant influenza vaccine approved in the European Union
November 20, 2020Medical Communications, Sales and Marketing Europe, influenza, pharma
The European Commission (EC) has just approved its first recombinant influenza vaccine for the European Union, awarding marketing authorisation to …
Top Ten most popular articles on Pharmafile.com this week
November 20, 2020Medical Communications
The top ten news stories this week centre around coronavirus vaccine clinical trial results, as Pfizer and BioNTech have backed …
Gilead’s lenacapavir meets primary goal in heavily treated and multidrug resistant HIV-1
November 19, 2020Research and Development Gilead, HIV, pharma
Gilead has pulled back the curtain on promising new data for its long-acting HIV-1 capsid inhibitor lenacapavir for heavily treated …
OPEN Health reveals new CEO appointment
November 19, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Open Health
Rob Barker has been named as the new Chief Executive Officer (CEO) at health communications and market access group OPEN …
First multiple sclerosis clinical trial for patients who can’t walk to begin recruitment
November 19, 2020Business Services
The first clinical trial to focus on multiple sclerosis (MS) patients who can’t walk will begin enrolling patients next year. …
Five Chinese coronavirus vaccines in overseas clinical trials
November 19, 2020Business Services
Five different coronavirus vaccines from China are being tested in Phase 3 trials around the world. The countries conducting the …
Vietnam selected as Asian pilot country for UK’s new global healthcare partnership
November 19, 2020Business Services
A new global healthcare partnership funded by the World Economic Forum (WEF), the London School of Economics and AstraZeneca has …
Bristol Myers Squibb completes $13.1 billion acquisition of MyoKardia
November 18, 2020Research and Development
Bristol Myers Squibb has announced that its acquisition of MyoKardia has been completed, with the transaction worth a total of …
NICE recommends Lilly’s Emgality for chronic and episodic migraine
November 18, 2020Research and Development, Sales and Marketing Eli Lilly, NHS, NICE, UK
Eli Lilly’s Emgality (galcanezumab) is set to become an approved option for the prevention of episodic and chronic migraine on …
FDA approves first at-home coronavirus self-testing kit
November 18, 2020Research and Development
The FDA has issued an Emergency Use Authorization for the first coronavirus self-testing kit for use at home that produces …
Pfizer/BioNTech’s COVID-19 vaccine shows up to 95% efficacy in final analysis, including in over-65s
November 18, 2020Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have backed up their promising interim Phase 3 data showing 90% efficacy for their COVID-19 vaccine candidate …
Pharmafile.com’s weekly COVID-19 news round-up
November 18, 2020Research and Development
The coronavirus news this week focuses on the Pfizer-BioNTech vaccine, with clinical trial participants receiving the vaccine saying it created …
AstraZeneca’s Brilinta reduces stroke and death risk in head and neck artery atherosclerosis patients
November 17, 2020Manufacturing and Production
AstraZeneca’s Brilinta (ticagrelor) reduced the composite of stroke and death in patients with head and neck artery atherosclerosis who had …
Pfizer takes legal action against Indian drugmakers over generic cancer drug
November 17, 2020Manufacturing and Production
Pfizer has filed a petition in a US court against Indian companies Dr Reddy’s Laboratories and Aurobindo Pharma that alleges …
Renewed BARDA backing boosts J&J’s COVID-19 vaccine funding by $1bn
November 17, 2020Manufacturing and Production, Research and Development BARDA, COVID-19, J&J, JJ, Janssen, Vaccine
Johnson & Johnson has said that it is injecting around $1 billion of funding into its research efforts to develop …
Pfizer launches pilot delivery programme for its coronavirus vaccine
November 17, 2020Manufacturing and Production
Pfizer is set to launch its first delivery programme for the COVID-19 vaccine it developed with BioNTech. It will be …
UK secures 5m doses of Moderna’s vaccine after it shows 94.5% interim efficacy
November 17, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, UK, Vaccine
US firm Moderna has swooped in with Phase 3 interim data for its own messenger RNA (mRNA) vaccine candidate, mRNA-1273, …
BioNTech Chief says COVID-19 vaccine could mean “normal winter” next year
November 16, 2020Research and Development, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine
The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor Uğur Şahin, Professor …
J&J launches second global COVID-19 vaccine trial, evaluating two-dose regimen
November 16, 2020Research and Development, Sales and Marketing COVID-19, J&J, JJ, Janssen, Vaccine
Johnson & Johnson has kicked off a second global Phase 3 trial to assess the safety and efficacy of its …
British Labour Party calls for new laws to tackle online anti-vaxx campaigns
November 16, 2020Sales and Marketing
The British Labour Party has called for the implementation of new legal measures to combat anti-vaccination campaigns on the internet …
Latest content
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
